Last updated 2026-07-26
- Raised $2.7M Seed round led by OurCrowd, Jan 2023
- Raised Series A, Apr 2024
Total raised
$2.7M
Last: Undisclosed Round 2024-05
Stage
Seed
Founded
2020
Headcount
4
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences
About
Genopore is an Israeli biotech startup developing a next-generation platform to directly identify and measure proteins, which are crucial biomarkers for disease detection, therapeutic monitoring, and drug development. The company's technology uses direct optical detection at the single-molecule level with tiny nanopores, advanced semiconductor chips, and AI-powered software to provide insights into the proteome. Genopore aims to offer a cost-effective, high-sensitivity, and high-accuracy system for early detection of cancer and other diseases, with potential applications in drug development, clinical settings, agriculture, food production, and academic research.
Funding history · 2 rounds · $2.7M total
2024-04
A Round
Undisclosed
2023-01
Seed
$2.7M
★ OurCrowd
Q&A
- What is Genopore's primary focus?
- Genopore is an Israeli biotech startup developing a next-generation platform for direct identification and measurement of proteins, which are crucial biomarkers for disease detection, therapeutic monitoring, and drug development.
- When was Genopore founded?
- Genopore was founded in December 2020.
- What is Genopore's total funding to date?
- Genopore has raised a total of $4,090,000 USD.
- When did Genopore complete its most recent funding round?
- Genopore completed a Seed funding round in May 2024, with M Ventures as a lead investor.
- Which investors participated in Genopore's November 2022 Seed round?
- M Ventures led Genopore's Seed funding round in November 2022.
- What technologies does Genopore utilize in its platform?
- Genopore's technology incorporates direct optical detection at the single-molecule level with tiny nanopores, advanced semiconductor chips, and AI-powered software.
- What are the potential applications of Genopore's technology?
- Genopore's technology has potential applications in early detection of cancer and other diseases, drug development, clinical settings, agriculture, food production, and academic research.
Team · 4
David Baum
Founder · Co-founder & CEO
Amit Meller
Founder · Co-founder & CSO
Yigal Leibe
Founder · Co-founder and VP R&D
Oren Mansour
Founder · Co-founder and COO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Semiconductors & ElectronicsSystem-on-a-chipSensingOpticArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProvidersLaboratoriesMedical Devices IndustryMedical Equipment
Business model
B2B
Tags
nanotechnologysemiconductorsmedical-devicessystem-on-chipoptical-sensorearly-detectiondiagnostics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | genopore.com/ |
|---|
Identifiers & details
| Legal name | GENOPORE LTD |
|---|---|
| Former names | Briatha |
| Founded | 2020-12 |
| Employees (exact) | 4 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | genopore.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516290905 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-12-03 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 5 — people (3), shares_capital (2) |
| Registered address | הקישון 18 יבנה |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-24 | עדכון דירקטורים-הסרת דירקטור |
| 2026-02-24 | עדכון דירקטורים-עדכון מנהלים |
| 2026-02-22 | עדכון דירקטורים-הוספת דירקטור |
| 2026-02-22 | העברת מניות |
| 2026-03-02 | שינוי בהרכב הון - מניות-שינוי סוג מניה |